Jason Bobe predicts how many people will have had their genome sequenced by 2015.
Steven Salzberg outlines the scientific stance of the major candidates in the upcoming US presidential elections.
Genetics and social networking are joining forces as more sequence data becomes available to consumers.
The National Academy of Sciences published a short book on evolution and creationism, making the case that believing in evolution does not preclude belief in God.
Science covers the presidential candidates, ALS, a moss genome, and more.
Thanks to errors in lab testing, thousands of breast cancer patients may have been steered toward the wrong therapeutic treatment, according to this article in the Wall Street Journal.
A blogger reports on tracing SNPs to a very specific ancestor.
A blogger wonders whether scientists make naturally good managers.
Wall Street Journal parses a $30 million donation that will allow the Weizmann Institute of Science to launch a preclinical research facility and a biomedical science school.
Tech Review covers research on the human microbiome that might help explain the rise in allergy rates in many countries.
Nature reports on Down's syndrome and tumors, NUMB, induced pluripotent stem cells, and more.
A blogger discusses consumer genomics and privacy from the viewpoint of Web 2.0.
Life in the lab have you down? A blogger posts on alternative careers to put that scientific degree to use without, you know, having to be a scientist.
Jonathan Eisen remembers Sam Karlin.
A UK newspaper considers the biggest scientific accomplishments of last year.
The Wall Street Journal says researchers are developing a genetic test that could spot cancer in a saliva sample.
Wired reports on a genotyping test to determine race that has police departments in a bind.
Testing bioinformatics software with data will help catch errors code testing didn't spot.
Now that the science of genetic variation has progressed enough, genetic tests are on the rise -- but there's still a shortage of people qualified to make sense of the results.
Wired hails the top 10 newly engineered organisms of 2007.
MIT's OpenCourseWare initiative is proving popular among students and fellow universities that are signing on to offer their own classes for free.
Scientists are still debating John Hawks' paper about accelerating human evolution.
Technology Review writes about biotech advances in 2007.
Getting drugs to market faster is in the news.
Charles Darwin's trip around the world began 176 years ago.
In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.
Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research.
Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.
In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.